#diabetes
Brazil Clears First Generic Copy of Novo Nordisk’s Ozempic Shot
Brazil approved the country’s first generic version of Novo Nordisk A/S’s Ozempic shot, opening the door to cheaper competition in one of the world’s fastest-growing markets for weight loss and diabetes drugs.
Why are Indians suddenly buying more vitamins after starting Ozempic-like weight loss drugs?
Demand for vitamin and nutritional supplements is surging in India. This trend follows the increased availability of semaglutide-based weight-loss and diabetes medicines. Doctors are advising patients on these drugs to take multivitamins and protein supplemen…
Dr Reddy’s launches oral semaglutide in India
Dr Reddys Laboratories has launched its oral semaglutide biosimilar for type 2 diabetes in India. The drug, Obeda, is available in three tablet strengths for daily use. This launch expands access to advanced diabetes care. Dr Reddys is the second Indian compa…
GLP-1 Agonists Market Outlook Report 2026-2034: New Entrants Face Barriers Due to Consolidation and Patent Protections, Yet Opportunities Lie Within Niche Areas and Emerging Markets
The GLP-1 Agonists Market offers growth opportunities due to rising diabetes cases, innovations in drug delivery, and personalized medicine. Strategic partnerships, especially in the Asia-Pacific, could capitalize on enhanced healthcare access. Challenges inc…
Dr Reddy’s launches oral semaglutide biosimilar Obeda
Dr. Reddy’s launches Obeda, an affordable oral semaglutide biosimilar for type 2 diabetes, enhancing treatment options in India.
BREAKINGDr Reddy's launches oral semaglutide biosimilar Obeda in India
Dr. Reddy's Laboratories proudly presents Obeda, a groundbreaking oral semaglutide biosimilar for managing Type 2 diabetes in India. This innovative treatment offers patients the ease of a once-daily oral dosage, available in various strengths to effectively …
Diabetes control: 7 low-glycemic foods doctors say may help keep blood sugar stable
Blood sugar spikes are a growing concern in India. Nutrition experts highlight that simple food choices can make a significant difference. Incorporating foods like oats, lentils, chickpeas, sattu, curd, certain vegetables, nuts, and whole fruits can help mana…
Type 2 diabetes: Symptoms, causes, and what science has to say
India grapples with a significant diabetes and prediabetes surge. Millions are affected, many unaware of their condition. High blood sugar silently harms the body, impacting vital organs. Early detection and lifestyle changes are crucial. Doctors emphasize pr…
Merck Foundation announces 124 Winners from 32 Countries for their "More Than a Mother" and "Diabetes and Hypertension" Media Awards 2025
Abuja [Nigeria]/ Mumbai (Maharashtra) [India], May 9: Merck Foundation, the philanthropic arm of Merck KGaA Germany, in partnership with the First Ladies of Africa, announced the winners of the Merck Foundation Media Recognition Awards 2025 under the categori…
Ozempic Market to Surpass USD 61.92 Billion by 2035 as GLP-1 Therapies Transform Diabetes and Obesity Care | SNS Insider
U.S. Ozempic Market to Witness Robust Growth, Reaching USD 23.94 Billion by 2035 with 11.45% CAGR U.S. Ozempic Market to Witness Robust Growth, Reaching USD 23.94 Billion by 2035 with 11.45% CAGR
Trulicity Market Size to Reach USD 15.30 Billion by 2035 with Strong Demand for Metabolic Treatments | SNS Insider
U.S. Trulicity Market to Reach USD 4.87 Billion by 2035 Driven by Rising Diabetes Prevalence U.S. Trulicity Market to Reach USD 4.87 Billion by 2035 Driven by Rising Diabetes Prevalence